Compare Etsy Inc (ETSY) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Repligen Corporation Common Stock — how do they compare? Etsy Inc trades at $83.32 (market cap $7.61B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Etsy Inc is more actively traded (3,831,386 versus 1,216,919). Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Repligen Corporation Common Stock for 0 Days on average.
| ETSY | RGEN | |
|---|---|---|
Market Cap | $7.61B | $11.31B |
Volume | 3,831,386 | 1,216,919 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $194.57 |
52-Week Low | $44.05 | $102.87 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $9.56B | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $79.28, up 3.05% today, with a bullish technical signal and strong institutional interest. Recent earnings beats and a 71.4% gross margin highlight operational strength, though net income margin compressed to 5.65% in 2025. The stock is near its consensus price target of $85.94, with positive sentiment driven by AI initiatives and partnership renewals.
Outlook is cautiously optimistic given analyst support and growth initiatives, but risks include high debt-to-asset ratio (105.48% in 2025) and competitive e-commerce pressures. Upside hinges on AI-driven personalization boosting revenue, while margin pressure and macroeconomic headwinds pose challenges.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
